PRESS RELEASE: Pittsburgh, United States – July, 2022 – mHealth Capabilities Post COVID-19
Mobile Healthcare is a key enabler in the digital transformation of the healthcare industry. The surge in digital healthcare has been driven by the critical need to avoid exposure to COVID-19. Healthcare providers and payers are embracing the change, which is evolving care coordination, maximizing outreach, boosting patient engagement, and improving outcomes, while minimizing costs.
mHealth offers a wealth of opportunities to the pharmaceutical industry, ranging from accelerated clinical trial innovation and medication adherence monitoring to securing the supply chain and combating counterfeit drugs. In addition, with the increasing prevalence of mobile apps that provide therapeutic impact, the digital therapeutics space is beginning to emerge, which may one day rival mainstream pharmaceuticals in areas such as chronic disease care.
Keen to monetize their vast wireless network assets, mobile operators view mHealth as a significant revenue opportunity – many are extending beyond providing pure connectivity services, towards end-to-end mHealth offerings such as remote patient monitoring.
The mHealth (Mobile Healthcare) Ecosystem: 2022 – 2030 Opportunities, Challenges, Strategies & Forecasts. Other stakeholders that are set to benefit from mHealth include but are not limited to connected medical and wearable device OEMs, app developers, Big Data and analytics specialists, cloud computing giants, and even ride-hailing providers such as Uber and Lyft – whose platforms are increasingly being integrated with healthcare IT systems, letting healthcare providers improve their level of care by booking rides for their patients.
Driven by the thriving ecosystem, SNS Research estimates that the mHealth market will account for more than $90 Billion in 2022 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Research estimates further growth at a CAGR of approximately 30% between 2022 to 2026.
The “mHealth (Mobile Healthcare) Ecosystem: 2022 – 2030 – Opportunities, Challenges, Strategies & Forecasts“ report presents an in-depth assessment of the mHealth ecosystem including market drivers, challenges, enabling technologies, applications, key trends, standardization, regulatory landscape, case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for mHealth investments from 2022 till 2030. The forecasts are segmented for 5 submarkets, 29 use case categories, 5 ecosystem player categories, 6 geographical regions and 34 countries.
The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.
About SNS Research
SNS Research is a global market intelligence and consulting firm with a particular focus on the healthcare and pharmaceutical industries. Our core team is based in Pennsylvania, USA, with industry expert analysts working around the world to deliver a comprehensive global outlook on a range of topics in the healthcare sector. Trusted by our clients to meet their research needs, we serve organizations of all sizes. Our customers comprise of government agencies, drug manufacturers, biopharmaceutical companies, healthcare providers, educational institutions, international regulatory authorities, and investment firms.
To Learn more contact us at: firstname.lastname@example.org
Our Research & Services